"GLUTAMAX" IN THE COMPLEX TREATMENT OF PSORIASIS
Abstract
The article presents the experience of using Glutamax in the systemic treatment of common forms of psoriasis.
The patients were followed up for 6 months. After use, there is a rapid regression of rashes, good tolerance, a
decrease in the level of blood biochemical parameters.
References
2. Kungurov N.V., Filimonkova N.N., Tuzankina I.A. Psoriaticheskaja bolezn'. Ekaterinburg: Izd. Ural'skogo universiteta 2002.
3. Kubanova A.A., Kubanov A.A., Nikolas Dzh. F. i dr. Immunnye mehanizmy psoriaza. Novye strategii biologicheskoj terapii. Vestn dermatol
i venerol 2010; 1: 35—47.
4. Kubanova A.A. Klinicheskie rekomendacii. Dermatovenerologija. M 2007.
5. Krueger J.G., Bowcock A. Psoriasis pathophysiology: current concepts of pathogenesis. Ann Rheum Dis 2005; 64: 30—36.
6. Storozhakov G.I., Bajkova I.E. Glicirrizin v lechenii hronicheskih virusnyh gepatitov. Klin farmakol i ter 2000; 9: 39—41.
7. Menter A., Griffiths C.E. Current and future management of psoriasis. Lancet 2007; 370: 272—284.
8. Nickoloff B.J., Nestle F.O. Recent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities. J Clin Invest 2004; 15:
1664—1675.
9. Filimonkova N.N. Psoriaticheskaja bolezn': kliniko-immunologicheskie varianty, patogeneticheskoe obosnovanie differencirovannoj terapii: Avtoref. dis. … dra med. nauk. Cheljabinsk 2001
CC BY-ND
A work licensed in this way allows the following:
1. The freedom to use and perform the work: The licensee must be allowed to make any use, private or public, of the work.
2. The freedom to study the work and apply the information: The licensee must be allowed to examine the work and to use the knowledge gained from the work in any way. The license may not, for example, restrict "reverse engineering."
2. The freedom to redistribute copies: Copies may be sold, swapped or given away for free, in the same form as the original.
